Verition Fund Management
MEDP icon

Verition Fund Management’s Medpace MEDP Stock Holding History

Verition Fund Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57M Buy
7,440
+2,420
+48% +$1.24M 0.02% 724
2025
Q4 		$2.82M Sell
5,020
-11,257
-69% -$6.39M 0.01% 1306
2025
Q3 		$8.37M Buy
16,277
+10,504
+182% +$4.59M 0.03% 652
2025
Q2 		$1.81M Buy
5,773
+2,364
+69% +$710K 0.01% 2029
2025
Q1 		$1.04M Buy
3,409
+1,532
+82% +$515K ﹤0.01% 2101
2024
Q4 		$624K Buy
+1,877
New +$637K ﹤0.01% 2340
2024
Q3 		– Sell
-2,276
Closed -$937K – 3401
2024
Q2 		$937K Buy
2,276
+1,385
+155% +$548K 0.01% 1716
2024
Q1 		$360K Buy
+891
New +$313K ﹤0.01% 2194
2023
Q3 		– Sell
-6,435
Closed -$1.55M – 2538
2023
Q2 		$1.55M Buy
6,435
+4,543
+240% +$944K 0.02% 789
2023
Q1 		$356K Buy
+1,892
New +$391K ﹤0.01% 1415
2018
Q4 		– Sell
-25,873
Closed -$1.55M – 1090
2018
Q3 		$1.55M Buy
+25,873
New +$1.42M 0.06% 397

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Verition Fund Management's MEDP Position: Q1 2026 in Review

Verition Fund Management increased its Medpace (MEDP) stake by 48% in Q1 2026, buying an estimated $1.24M and bringing the position to 7,440 shares worth $3.57M. The position accounts for 0.02% of the portfolio, ranked #724.

Verition Fund Management first reported a position in MEDP in Q3 2018 and has held it in 11 quarters since. The position peaked at $8.37M in Q3 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Verition Fund Management held 7,440 shares of Medpace worth $3.57M as of Q1 2026.
  • Verition Fund Management bought 2,420 Medpace shares in Q1 2026, an estimated $1.24M.
  • Medpace made up 0.02% of Verition Fund Management's portfolio in Q1 2026, its #724 holding.
  • Verition Fund Management first reported a position in Medpace in Q3 2018 and has held it in 11 quarters since.
  • Verition Fund Management's Medpace position peaked at $8.37M in Q3 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.